Plastics Capital Plc - Trading update
Plastics Capital (LON:PLA) released a trading update on May 2, for the year ending March 31. The company reports that trading remains broadly in line with market expectations. The statement confirms a strong annual revenue growth, reflecting the contribution from the acquired CCM creasing matrix business and also increased organic growth, led by the Films division.
The strong revenue performance reflects a strategy shift undertaken last year to focus more on top-line growth.
EBITDA MARGIN DILUTION
As per the trading update in February, the company confirms that there is some EBITDA margin dilution. We are now forecasting a FY Mar18 EBITDA margin of 9.1% versus 10.4% in the previous year. This is a reduction versus our previous forecast of 9.3% reflecting cost investments relating to the growth strategy, and a mix shift towards lower margin Films revenues whilst some higher margin revenues in the Bearings business have been delayed.
THE BEARINGS BUSINESS
The company has previously cautioned that some large contracts within the Bearings business are experiencing slower revenue ramp-up than originally anticipated. In the latest release, the company reports “some improvement in this situation”, together with initial revenues coming through from additional contracts more recently signed.
There remains a negative group EBITDA impact for FY Mar2018 due to the delays in this high margin business. However, we believe that the Bearings business is now positioned to make positive incremental contributions from FY Mar2019 onwards.
During the last two years Plastics Capital (LON:PLA) has undertaken a significant programme of investments, including £3.4m of capex for new production capacity and £0.7m investment in new capabilities and specific customer projects. The benefits of these investments are evident in the current level of revenue growth, and we believe that profitability will follow suit in FY Mar2019 and going forwards due to operating leverage and more favourable mix.
Quick facts: Synnovia PLC
Price: 124.5 GBX
Market Cap: £48.55 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Synnovia PLC named herein, including the promotion by the Company of Synnovia PLC in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE
LEGAL NOTICE – IMPORTANT – PLEASE READ:
Proactive Research is a trading name of Proactive Investors Limited which is regulated and authorised by the Financial Conduct Authority (FCA) under firm registration...FOR OUR FULL DISCLAIMER CLICK HERE